Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
Posted on Thursday, September 1, 2011 - 10:50, By: Amy Madsen
In its latest round of funding this July, MDA awarded nine grants totaling more than $2.5 million to research projects focused on uncovering the causes of, and developing therapies for, amyotrophic lateral sclerosis (ALS).
The new grants were awarded to investigators at labs in the United States...
ALS TDI scientists provided updates on the development and testing of several therapies designed to slow and stop ALS
Posted on Thursday, April 21, 2011 - 10:45, By: Amy Madsen
The state of the science in ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease), current lines of research, efforts to establish a TDP43 research mouse colony, and a primer on protein-based therapies were the topics of a webcast on April 7, 2011, presented by ALS Therapy Development...
Ten leaders in the field of ALS research put their heads together on Oct. 24, 2009
Posted on Friday, October 30, 2009 - 13:35, By: ALSN Staff
An all-day "think tank" to consider priorities for amyotrophic lateral sclerosis (ALS) research based on the latest information was conducted with ten of the leading scientists and clinicians in the field and senior MDA staff in Tucson, Ariz., on Saturday, Oct. 24, 2009.